THE MEDIAN EYE OF LIMULUS: AN ULTRAVIOLET RECEPTOR
1963; National Academy of Sciences; Volume: 50; Issue: 6 Linguagem: Inglês
10.1073/pnas.50.6.1011
ISSN1091-6490
AutoresGeorge Wald, James M. Krainin,
Tópico(s)Antioxidant Activity and Oxidative Stress
ResumoCurrently, no pharmacological therapies treat skeletal muscle insulin resistance in pathological conditions such as type 2 diabetes, age-associated diseases, and cancer. Therefore, there is an unmet need to identify the molecular mechanisms ...The molecular events governing skeletal muscle glucose uptake have pharmacological potential for managing insulin resistance in conditions such as obesity, diabetes, and cancer. With no current pharmacological treatments to target skeletal muscle insulin ...
Referência(s)